RNA interference (RNAi) is a collection of small RNA directed mechanisms that result in sequence specific inhibition of gene expression. The notion that RNAi could lead to a new class of therapeutics caught the attention of many investigators soon after its discovery. The field of applied RNAi therapeutics has moved very quickly from lab to bedside. The RNAi approach has been widely used for drug development and several phase I and II clinical trials are under way. However, there are still some concerns and challenges to overcome for therapeutic applications. These include the potential for off-target effects, triggering innate immune responses and most importantly obtaining specific delivery into the cytoplasm of target cells.
The report focuses on the RNAi for Therapeutic market size, segment size (mainly covering product type, application, and geography), competitor landscape, recent status, and development trends. Furthermore, the report provides strategies for companies to overcome threats posed by COVID-19.
Technological innovation and advancement will further optimize the performance of the product, enabling it to acquire a wider range of applications in the downstream market. Moreover, customer preference analysis, market dynamics (drivers, restraints, opportunities), new product release, impact of COVID-19, regional conflicts and carbon neutrality provide crucial information for us to take a deep dive into the RNAi for Therapeutic market.
Major Players in the RNAi for Therapeutic market are:
Benitec Biopharma
CombiMatrix
Celsion Corporation
Quark Pharmaceuticals
Arrowhead Research
BioSpring
Roche Innovation Center Copenhagen (formerly Santaris Pharma)
Sylentis
Silenseed
Bayer Heathcare
Celgene
Calando Pharmaceuticals
GeneCopoeia
Ascletis Pharmaceuticals
Biogazelle
Gradalis Incorporated
AstraZeneca
Astellas Pharma
RXi Pharmaceuticals
Alnylam Pharmaceuticals
Ensysce Biosciences
Tekmira Pharmaceuticals.
Silence Therapeutics
Creative Animodel
On the basis of types, the RNAi for Therapeutic market is primarily split into:
siRNA
miRNA
shRNA
On the basis of applications, the market covers:
Cancer
Cardiovascular
HBV
Others
Major Regions or countries covered in this report:
United States
Europe
China
Japan
India
Southeast Asia
Latin America
Middle East and Africa
Others
Years considered for this report:
Historical Years: 2017-2021
Base Year: 2021
Estimated Year: 2022
Forecast Period: 2022-2029
Global RNAi for Therapeutic Market Research Report 2022 - Market Size, Current Insights and Development Trends
Table of Content
1 RNAi for Therapeutic Market Overview
1.1 Product Overview and Scope of RNAi for Therapeutic Market
1.2 RNAi for Therapeutic Market Segment by Type
1.2.1 Global RNAi for Therapeutic Market Sales and CAGR (%) Comparison by Type (2017-2029)
1.3 Global RNAi for Therapeutic Market Segment by Application
1.3.1 RNAi for Therapeutic Market Consumption (Sales) Comparison by Application (2017-2029)
1.4 Global RNAi for Therapeutic Market, Region Wise (2017-2029)
1.5 Global Market Size (Revenue) of RNAi for Therapeutic (2017-2029)
1.5.1 Global RNAi for Therapeutic Market Revenue Status and Outlook (2017-2029)
1.5.2 Global RNAi for Therapeutic Market Sales Status and Outlook (2017-2029)
1.6 Influence of Regional Conflicts on the RNAi for Therapeutic Industry
1.7 Impact of Carbon Neutrality on the RNAi for Therapeutic Industry
2 RNAi for Therapeutic Market Upstream and Downstream Analysis
2.1 RNAi for Therapeutic Industrial Chain Analysis
2.2 Key Raw Materials Suppliers and Price Analysis
2.3 Key Raw Materials Supply and Demand Analysis
2.4 Market Concentration Rate of Raw Materials
2.5 Manufacturing Process Analysis
2.6 Manufacturing Cost Structure Analysis
2.6.1 Labor Cost Analysis
2.6.2 Energy Costs Analysis
2.6.3 R&D Costs Analysis
2.7 Major Downstream Buyers of RNAi for Therapeutic Analysis
2.8 Impact of COVID-19 on the Industry Upstream and Downstream
3 Players Profiles
3.1 Benitec Biopharma
3.1.1 Benitec Biopharma Basic Information, Manufacturing Base, Sales Area and Competitors
3.1.2 Product Profiles, Application and Specification
3.1.3 RNAi for Therapeutic Market Performance (2017-2022)
3.1.4 Business Overview
3.2 CombiMatrix
3.2.1 CombiMatrix Basic Information, Manufacturing Base, Sales Area and Competitors
3.2.2 Product Profiles, Application and Specification
3.2.3 RNAi for Therapeutic Market Performance (2017-2022)
3.2.4 Business Overview
3.3 Celsion Corporation
3.3.1 Celsion Corporation Basic Information, Manufacturing Base, Sales Area and Competitors
3.3.2 Product Profiles, Application and Specification
3.3.3 RNAi for Therapeutic Market Performance (2017-2022)
3.3.4 Business Overview
3.4 Quark Pharmaceuticals
3.4.1 Quark Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Competitors
3.4.2 Product Profiles, Application and Specification
3.4.3 RNAi for Therapeutic Market Performance (2017-2022)
3.4.4 Business Overview
3.5 Arrowhead Research
3.5.1 Arrowhead Research Basic Information, Manufacturing Base, Sales Area and Competitors
3.5.2 Product Profiles, Application and Specification
3.5.3 RNAi for Therapeutic Market Performance (2017-2022)
3.5.4 Business Overview
3.6 BioSpring
3.6.1 BioSpring Basic Information, Manufacturing Base, Sales Area and Competitors
3.6.2 Product Profiles, Application and Specification
3.6.3 RNAi for Therapeutic Market Performance (2017-2022)
3.6.4 Business Overview
3.7 Roche Innovation Center Copenhagen (formerly Santaris Pharma)
3.7.1 Roche Innovation Center Copenhagen (formerly Santaris Pharma) Basic Information, Manufacturing Base, Sales Area and Competitors
3.7.2 Product Profiles, Application and Specification
3.7.3 RNAi for Therapeutic Market Performance (2017-2022)
3.7.4 Business Overview
3.8 Sylentis
3.8.1 Sylentis Basic Information, Manufacturing Base, Sales Area and Competitors
3.8.2 Product Profiles, Application and Specification
3.8.3 RNAi for Therapeutic Market Performance (2017-2022)
3.8.4 Business Overview
3.9 Silenseed
3.9.1 Silenseed Basic Information, Manufacturing Base, Sales Area and Competitors
3.9.2 Product Profiles, Application and Specification
3.9.3 RNAi for Therapeutic Market Performance (2017-2022)
3.9.4 Business Overview
3.10 Bayer Heathcare
3.10.1 Bayer Heathcare Basic Information, Manufacturing Base, Sales Area and Competitors
3.10.2 Product Profiles, Application and Specification
3.10.3 RNAi for Therapeutic Market Performance (2017-2022)
3.10.4 Business Overview
3.11 Celgene
3.11.1 Celgene Basic Information, Manufacturing Base, Sales Area and Competitors
3.11.2 Product Profiles, Application and Specification
3.11.3 RNAi for Therapeutic Market Performance (2017-2022)
3.11.4 Business Overview
3.12 Calando Pharmaceuticals
3.12.1 Calando Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Competitors
3.12.2 Product Profiles, Application and Specification
3.12.3 RNAi for Therapeutic Market Performance (2017-2022)
3.12.4 Business Overview
3.13 GeneCopoeia
3.13.1 GeneCopoeia Basic Information, Manufacturing Base, Sales Area and Competitors
3.13.2 Product Profiles, Application and Specification
3.13.3 RNAi for Therapeutic Market Performance (2017-2022)
3.13.4 Business Overview
3.14 Ascletis Pharmaceuticals
3.14.1 Ascletis Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Competitors
3.14.2 Product Profiles, Application and Specification
3.14.3 RNAi for Therapeutic Market Performance (2017-2022)
3.14.4 Business Overview
3.15 Biogazelle
3.15.1 Biogazelle Basic Information, Manufacturing Base, Sales Area and Competitors
3.15.2 Product Profiles, Application and Specification
3.15.3 RNAi for Therapeutic Market Performance (2017-2022)
3.15.4 Business Overview
3.16 Gradalis Incorporated
3.16.1 Gradalis Incorporated Basic Information, Manufacturing Base, Sales Area and Competitors
3.16.2 Product Profiles, Application and Specification
3.16.3 RNAi for Therapeutic Market Performance (2017-2022)
3.16.4 Business Overview
3.17 AstraZeneca
3.17.1 AstraZeneca Basic Information, Manufacturing Base, Sales Area and Competitors
3.17.2 Product Profiles, Application and Specification
3.17.3 RNAi for Therapeutic Market Performance (2017-2022)
3.17.4 Business Overview
3.18 Astellas Pharma
3.18.1 Astellas Pharma Basic Information, Manufacturing Base, Sales Area and Competitors
3.18.2 Product Profiles, Application and Specification
3.18.3 RNAi for Therapeutic Market Performance (2017-2022)
3.18.4 Business Overview
3.19 RXi Pharmaceuticals
3.19.1 RXi Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Competitors
3.19.2 Product Profiles, Application and Specification
3.19.3 RNAi for Therapeutic Market Performance (2017-2022)
3.19.4 Business Overview
3.20 Alnylam Pharmaceuticals
3.20.1 Alnylam Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Competitors
3.20.2 Product Profiles, Application and Specification
3.20.3 RNAi for Therapeutic Market Performance (2017-2022)
3.20.4 Business Overview
3.21 Ensysce Biosciences
3.21.1 Ensysce Biosciences Basic Information, Manufacturing Base, Sales Area and Competitors
3.21.2 Product Profiles, Application and Specification
3.21.3 RNAi for Therapeutic Market Performance (2017-2022)
3.21.4 Business Overview
3.22 Tekmira Pharmaceuticals.
3.22.1 Tekmira Pharmaceuticals. Basic Information, Manufacturing Base, Sales Area and Competitors
3.22.2 Product Profiles, Application and Specification
3.22.3 RNAi for Therapeutic Market Performance (2017-2022)
3.22.4 Business Overview
3.23 Silence Therapeutics
3.23.1 Silence Therapeutics Basic Information, Manufacturing Base, Sales Area and Competitors
3.23.2 Product Profiles, Application and Specification
3.23.3 RNAi for Therapeutic Market Performance (2017-2022)
3.23.4 Business Overview
3.24 Creative Animodel
3.24.1 Creative Animodel Basic Information, Manufacturing Base, Sales Area and Competitors
3.24.2 Product Profiles, Application and Specification
3.24.3 RNAi for Therapeutic Market Performance (2017-2022)
3.24.4 Business Overview
4 Global RNAi for Therapeutic Market Landscape by Player
4.1 Global RNAi for Therapeutic Sales and Share by Player (2017-2022)
4.2 Global RNAi for Therapeutic Revenue and Market Share by Player (2017-2022)
4.3 Global RNAi for Therapeutic Average Price by Player (2017-2022)
4.4 Global RNAi for Therapeutic Gross Margin by Player (2017-2022)
4.5 RNAi for Therapeutic Market Competitive Situation and Trends
4.5.1 RNAi for Therapeutic Market Concentration Rate
4.5.2 RNAi for Therapeutic Market Share of Top 3 and Top 6 Players
4.5.3 Mergers & Acquisitions, Expansion
5 Global RNAi for Therapeutic Sales, Revenue, Price Trend by Type
5.1 Global RNAi for Therapeutic Sales and Market Share by Type (2017-2022)
5.2 Global RNAi for Therapeutic Revenue and Market Share by Type (2017-2022)
5.3 Global RNAi for Therapeutic Price by Type (2017-2022)
5.4 Global RNAi for Therapeutic Sales, Revenue and Growth Rate by Type (2017-2022)
5.4.1 Global RNAi for Therapeutic Sales, Revenue and Growth Rate of siRNA (2017-2022)
5.4.2 Global RNAi for Therapeutic Sales, Revenue and Growth Rate of miRNA (2017-2022)
5.4.3 Global RNAi for Therapeutic Sales, Revenue and Growth Rate of shRNA (2017-2022)
6 Global RNAi for Therapeutic Market Analysis by Application
6.1 Global RNAi for Therapeutic Consumption and Market Share by Application (2017-2022)
6.2 Global RNAi for Therapeutic Consumption Revenue and Market Share by Application (2017-2022)
6.3 Global RNAi for Therapeutic Consumption and Growth Rate by Application (2017-2022)
6.3.1 Global RNAi for Therapeutic Consumption and Growth Rate of Cancer (2017-2022)
6.3.2 Global RNAi for Therapeutic Consumption and Growth Rate of Cardiovascular (2017-2022)
6.3.3 Global RNAi for Therapeutic Consumption and Growth Rate of HBV (2017-2022)
6.3.4 Global RNAi for Therapeutic Consumption and Growth Rate of Others (2017-2022)
7 Global RNAi for Therapeutic Sales and Revenue Region Wise (2017-2022)
7.1 Global RNAi for Therapeutic Sales and Market Share, Region Wise (2017-2022)
7.2 Global RNAi for Therapeutic Revenue and Market Share, Region Wise (2017-2022)
7.3 Global RNAi for Therapeutic Sales, Revenue, Price and Gross Margin (2017-2022)
7.4 United States RNAi for Therapeutic Sales, Revenue, Price and Gross Margin (2017-2022)
7.5 Europe RNAi for Therapeutic Sales, Revenue, Price and Gross Margin (2017-2022)
7.6 China RNAi for Therapeutic Sales, Revenue, Price and Gross Margin (2017-2022)
7.7 Japan RNAi for Therapeutic Sales, Revenue, Price and Gross Margin (2017-2022)
7.8 India RNAi for Therapeutic Sales, Revenue, Price and Gross Margin (2017-2022)
7.9 Southeast Asia RNAi for Therapeutic Sales, Revenue, Price and Gross Margin (2017-2022)
7.10 Latin America RNAi for Therapeutic Sales, Revenue, Price and Gross Margin (2017-2022)
7.11 Middle East and Africa RNAi for Therapeutic Sales, Revenue, Price and Gross Margin (2017-2022)
8 Global RNAi for Therapeutic Market Forecast (2022-2029)
8.1 Global RNAi for Therapeutic Sales, Revenue Forecast (2022-2029)
8.1.1 Global RNAi for Therapeutic Sales and Growth Rate Forecast (2022-2029)
8.1.2 Global RNAi for Therapeutic Revenue and Growth Rate Forecast (2022-2029)
8.1.3 Global RNAi for Therapeutic Price and Trend Forecast (2022-2029)
8.2 Global RNAi for Therapeutic Sales and Revenue Forecast, Region Wise (2022-2029)
8.2.1 United States RNAi for Therapeutic Sales and Revenue Forecast (2022-2029)
8.2.2 Europe RNAi for Therapeutic Sales and Revenue Forecast (2022-2029)
8.2.3 China RNAi for Therapeutic Sales and Revenue Forecast (2022-2029)
8.2.4 Japan RNAi for Therapeutic Sales and Revenue Forecast (2022-2029)
8.2.5 India RNAi for Therapeutic Sales and Revenue Forecast (2022-2029)
8.2.6 Southeast Asia RNAi for Therapeutic Sales and Revenue Forecast (2022-2029)
8.2.7 Latin America RNAi for Therapeutic Sales and Revenue Forecast (2022-2029)
8.2.8 Middle East and Africa RNAi for Therapeutic Sales and Revenue Forecast (2022-2029)
8.3 Global RNAi for Therapeutic Sales, Revenue and Price Forecast by Type (2022-2029)
8.3.1 Global RNAi for Therapeutic Revenue and Growth Rate of siRNA (2022-2029)
8.3.2 Global RNAi for Therapeutic Revenue and Growth Rate of miRNA (2022-2029)
8.3.3 Global RNAi for Therapeutic Revenue and Growth Rate of shRNA (2022-2029)
8.4 Global RNAi for Therapeutic Consumption Forecast by Application (2022-2029)
8.4.1 Global RNAi for Therapeutic Consumption Value and Growth Rate of Cancer (2022-2029)
8.4.2 Global RNAi for Therapeutic Consumption Value and Growth Rate of Cardiovascular (2022-2029)
8.4.3 Global RNAi for Therapeutic Consumption Value and Growth Rate of HBV (2022-2029)
8.4.4 Global RNAi for Therapeutic Consumption Value and Growth Rate of Others (2022-2029)
8.5 RNAi for Therapeutic Market Forecast Under COVID-19
9 Industry Outlook
9.1 RNAi for Therapeutic Market Drivers Analysis
9.2 RNAi for Therapeutic Market Restraints and Challenges
9.3 RNAi for Therapeutic Market Opportunities Analysis
9.4 Emerging Market Trends
9.5 RNAi for Therapeutic Industry Technology Status and Trends
9.6 News of Product Release
9.7 Consumer Preference Analysis
9.8 RNAi for Therapeutic Industry Development Trends under COVID-19 Outbreak
9.8.1 Global COVID-19 Status Overview
9.8.2 Influence of COVID-19 Outbreak on RNAi for Therapeutic Industry Development
10 Research Findings and Conclusion
11 Appendix
11.1 Methodology
11.2 Research Data Source
Global Targeted RNA Sequencing Market Research Report 2024
Published: 08-Jan-2024 Price: US 2900 Onwards Pages: 71
Targeted RNA-sequencing (RNA-Seq) is a highly accurate method for selecting and sequencing specific transcripts of interest and offers both quantitative and qualitative information. Targeted RNA-Seq can be achieved via either enrichment or amplicon-based approaches, both of which enable gene expression analysis in a focused set of genes of interest, with enrichment assays also providing The ability to detect both known and novel gene fusion partners in many sample types.
In The report, we ......
Global Targeted RNA Sequencing Market Growth (Status and Outlook) 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 87
According to our LPI (LP Information) latest study, the global Targeted RNA Sequencing market size was valued at US$ 1761.4 million in 2023. With growing demand in downstream market, the Targeted RNA Sequencing is forecast to a readjusted size of US$ 7649.2 million by 2030 with a CAGR of 23.3% during review period.
The research report highlights the growth potential of the global Targeted RNA Sequencing market. Targeted RNA Sequencing are expected to show stable growth in the future mark......
Global Targeted RNA Sequencing Market 2024 by Company, Regions, Type and Application, Forecast to 2030
Published: 01-Jan-2024 Price: US 3480 Onwards Pages: 94
According to our (Global Info Research) latest study, the global Targeted RNA Sequencing market size was valued at USD 1852.7 million in 2023 and is forecast to a readjusted size of USD 7255.4 million by 2030 with a CAGR of 21.5% during review period.
Targeted RNA-sequencing (RNA-Seq) is a highly accurate method for selecting and sequencing specific transcripts of interest and offers both quantitative and qualitative information. Targeted RNA-Seq can be achieved via either enrichment or ......
Global Antisense and RNAi Therapeutics Market Research Report 2023, Forecast to 2028
Published: 26-Dec-2023 Price: US 2680 Onwards Pages: 133
Antisense therapy means the selective, sequence-specific inhibition of gene expression by single-stranded DNA oligonucleotides. In contrast, RNA interference (RNAi) is triggered by double-stranded RNA (dsRNA) and causes sequence-specific mRNA degradation of single-stranded target RNAs in response to dsRNA.
Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (millio......
Global Antisense and RNAi Therapeutics Professional Survey Report 2023, Forecast to 2028
Published: 26-Dec-2023 Price: US 3280 Onwards Pages: 101
Antisense therapy means the selective, sequence-specific inhibition of gene expression by single-stranded DNA oligonucleotides. In contrast, RNA interference (RNAi) is triggered by double-stranded RNA (dsRNA) and causes sequence-specific mRNA degradation of single-stranded target RNAs in response to dsRNA.
Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (millio......
Global Targeted RNA Sequencing Market Research Report 2023, Forecast to 2028
Published: 13-Nov-2023 Price: US 2680 Onwards Pages: 137
Targeted RNA-sequencing (RNA-Seq) is a highly accurate method for selecting and sequencing specific transcripts of interest.
Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product ......
Global Targeted RNA Sequencing Professional Survey Report 2023, Forecast to 2028
Published: 13-Nov-2023 Price: US 3280 Onwards Pages: 100
Targeted RNA-sequencing (RNA-Seq) is a highly accurate method for selecting and sequencing specific transcripts of interest.
Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product ......
Global RNAi for Therapeutic Market Status and Outlook 2023-2028
Published: 08-Nov-2023 Price: US 3160 Onwards Pages: 106
RNAi is a fundamental cellular mechanism for silencing gene expression that can be harnessed for the development of new drugs
Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product ......
Global RNAi for Therapeutic Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 24-Oct-2023 Price: US 3380 Onwards Pages: 104
Market Overview of Global RNAi for Therapeutic market:
According to our latest research, the global RNAi for Therapeutic market looks promising in the next 5 years. As of 2022, the global RNAi for Therapeutic market was estimated at USD 260.55 million, and it's anticipated to reach USD 3633.33 million in 2028, with a CAGR of 55.14% during the forecast years.
RNA interference (RNAi) is a collection of small RNA directed mechanisms that result in sequence specific inhibition of......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
